Cardiac complications in thalassemia throughout the lifespan: Victories and challenges
出版年份 2023 全文链接
标题
Cardiac complications in thalassemia throughout the lifespan: Victories and challenges
作者
关键词
-
出版物
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2023-10-30
DOI
10.1111/nyas.15078
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Overall and complication‐free survival in a large cohort of patients with β ‐thalassemia major followed over 50 years
- (2023) Gian Luca Forni et al. AMERICAN JOURNAL OF HEMATOLOGY
- Mortality in β-thalassemia patients with confirmed pulmonary arterial hypertension on right heart catheterization
- (2022) Valeria M Pinto et al. BLOOD
- Atrial Fibrillation in β-Thalassemia: Overview of Mechanism, Significance and Clinical Management
- (2022) Michele Malagù et al. Biology-Basel
- Pulmonary hypertension in thalassemia: a call to action
- (2022) John C. Wood BLOOD
- 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary
- (2022) Paul A. Heidenreich et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Luspatercept, a two‐edged sword in beta‐thalassemia‐associated paravertebral extramedullary hematopoietic masses (EHMs)
- (2022) Ferras Alashkar et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Heart Failure with Preserved Ejection Fraction: Mechanisms and Treatment Strategies
- (2021) Kazunori Omote et al. Annual Review of Medicine
- A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia
- (2020) M. Domenica Cappellini et al. NEW ENGLAND JOURNAL OF MEDICINE
- Deferiprone increases endothelial nitric oxide synthase phosphorylation and nitric oxide production
- (2018) Thanaporn Sriwantana et al. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
- Left Ventricular Diastolic Dysfunction in β-Thalassemia Major with Heart Failure
- (2018) Luigi Mancuso et al. HEMOGLOBIN
- National registry of hemoglobinopathies in Greece: updated demographics, current trends in affected births, and causes of mortality
- (2018) Ersi Voskaridou et al. ANNALS OF HEMATOLOGY
- Microparticles from β-thalassaemia/HbE patients induce endothelial cell dysfunction
- (2018) Wasinee Kheansaard et al. Scientific Reports
- Haemodynamic definitions and updated clinical classification of pulmonary hypertension
- (2018) Gérald Simonneau et al. EUROPEAN RESPIRATORY JOURNAL
- Red blood cell-derived microparticles: An overview
- (2016) Maxwell Westerman et al. BLOOD CELLS MOLECULES AND DISEASES
- Pulmonary hypertension in well-transfused thalassemia major patients
- (2015) Antonella Meloni et al. BLOOD CELLS MOLECULES AND DISEASES
- Synergistic intracellular iron chelation combinations: mechanisms and conditions for optimizing iron mobilization
- (2015) Evangelia Vlachodimitropoulou Koumoutsea et al. BRITISH JOURNAL OF HAEMATOLOGY
- Myocardial fibrosis by late gadolinium enhancement cardiac magnetic resonance and hepatitis C virus infection in thalassemia major patients
- (2015) Alessia Pepe et al. Journal of Cardiovascular Medicine
- The deferiprone and deferasirox combination is efficacious in iron overloaded patients with β-thalassemia major: A prospective, single center, open-label study
- (2015) Sidharth Totadri et al. PEDIATRIC BLOOD & CANCER
- Efficacy and safety of sildenafil for the treatment of severe pulmonary hypertension in patients with hemoglobinopathies: results from a long-term follow up
- (2014) G. Derchi et al. HAEMATOLOGICA
- The pathophysiological relationship and clinical significance of left atrial function and left ventricular diastolic dysfunction in β-thalassemia major
- (2013) Anna G. Kostopoulou et al. AMERICAN JOURNAL OF HEMATOLOGY
- Twice daily deferasirox significantly improves clinical efficacy in transfusion dependent thalassaemias who were inadequate responders to standard once daily dose
- (2013) Bunchoo Pongtanakul et al. BLOOD CELLS MOLECULES AND DISEASES
- Cardiovascular Function and Treatment in β-Thalassemia Major
- (2013) Dudley J. Pennell et al. CIRCULATION
- Assessment of left ventricular and atrial diastolic function using two-dimensional (2D) strain imaging in patients with β-thalassemia major
- (2013) Alexandra G. Karamanou et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Sildenafil therapy in thalassemia patients with Doppler-defined risk of pulmonary hypertension
- (2013) C. R. Morris et al. HAEMATOLOGICA
- A Novel Paradigm for Heart Failure With Preserved Ejection Fraction
- (2013) Walter J. Paulus et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Combined chelation therapy with deferasirox and deferoxamine in thalassemia
- (2012) Ashutosh Lal et al. BLOOD CELLS MOLECULES AND DISEASES
- Vascular Endothelial Dysfunction in β-Thalassemia Occurs Despite Increased eNOS Expression and Preserved Vascular Smooth Muscle Cell Reactivity to NO
- (2012) Ekatherina Stoyanova et al. PLoS One
- The WHO Classification of Pulmonary Hypertension: A Case-Based Imaging Compendium
- (2012) John J. Ryan et al. Pulmonary Circulation
- Electrocardiographic consequences of cardiac iron overload in thalassemia major
- (2011) Jon Detterich et al. AMERICAN JOURNAL OF HEMATOLOGY
- Risk factors and mortality associated with an elevated tricuspid regurgitant jet velocity measured by Doppler-echocardiography in thalassemia: a Thalassemia Clinical Research Network report
- (2011) C. R. Morris et al. BLOOD
- Dispersion of repolarization and beta-thalassemia major: the prognostic role of QT and JT dispersion for identifying the high-risk patients for sudden death
- (2011) Vincenzo Russo et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Risk factors for pulmonary hypertension in patients with β thalassemia intermedia
- (2011) Mehran Karimi et al. European Journal of Internal Medicine
- Relationship between labile plasma iron, liver iron concentration and cardiac response in a deferasirox monotherapy trial
- (2011) J. C. Wood et al. HAEMATOLOGICA
- Elevated liver iron concentration is a marker of increased morbidity in patients with thalassemia intermedia
- (2011) K. M. Musallam et al. HAEMATOLOGICA
- Pulmonary hypertension in thalassemia
- (2010) Claudia R. Morris et al. Annals of the New York Academy of Sciences
- The effect of deferasirox on cardiac iron in thalassemia major: impact of total body iron stores
- (2010) J. C. Wood et al. BLOOD
- High levels of placenta growth factor in sickle cell disease promote pulmonary hypertension
- (2010) N. Sundaram et al. BLOOD
- Nutritional deficiencies in iron overloaded patients with hemoglobinopathies
- (2009) Susan Claster et al. AMERICAN JOURNAL OF HEMATOLOGY
- Efficacy of deferasirox in reducing and preventing cardiac iron overload in -thalassemia
- (2009) D. J. Pennell et al. BLOOD
- Deferasirox pharmacokinetics in patients with adequate versus inadequate response
- (2009) D. Chirnomas et al. BLOOD
- Myocardial scarring by delayed enhancement cardiovascular magnetic resonance in thalassaemia major
- (2009) A Pepe et al. HEART
- Cardiac Complications in Thalassemia Major
- (2009) John C. Wood HEMOGLOBIN
- Longitudinal analysis of heart and liver iron in thalassemia major
- (2008) L. J. Noetzli et al. BLOOD
- Placenta growth factor augments endothelin-1 and endothelin-B receptor expression via hypoxia-inducible factor-1
- (2008) N. Patel et al. BLOOD
- Effect of deferasirox (ICL670) on arterial function in patients with beta-thalassaemia major
- (2008) Y. F. Cheung et al. BRITISH JOURNAL OF HAEMATOLOGY
- Vitamin D deficiency, cardiac iron and cardiac function in thalassaemia major
- (2008) John C. Wood et al. BRITISH JOURNAL OF HAEMATOLOGY
- Atrial dysfunction as a marker of iron cardiotoxicity in thalassemia major
- (2008) W. Li et al. HAEMATOLOGICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started